Biomatter

We build impossible enzymes for your visionary products.

Biomatter was founded in 2018, is headquartered in Vilnius, Lithuania, and has $6.5M in recorded funding across 1 round.

Headquarters
Vilnius
Founded
2018
Business Model
B2B
Total Funding
$6.5M
Last Round
$6.5M SeedAug 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Biomatter is a synthetic biology company based in Vilnius, Lithuania, that builds exceptional enzymes for health and sustainable manufacturing applications. Its proprietary Intelligent Architecture™ platform enables near-perfect control over protein design, allowing creation of previously impossible enzymes and enzyme-based products. Biomatter partners with leading global companies on projects ranging from stand-alone enzyme products to multi-enzyme chemical manufacturing solutions, supporting clients from initial concept and design through experimental validation, scale-up, and protein production.

Summary

Biomatter is a Biotech company based in Vilnius, Lithuania, founded in 2018. It has raised $6.5M in total across 1 round, most recently a $6.5M Seed round in Aug 2024.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedAug 2024
$6.5M

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Biomatter on Indexed.vc
<a href="https://indexed.vc/companies/biomatter"><img src="https://indexed.vc/api/badge/company/biomatter" alt="Biomatter on Indexed.vc" width="260" height="76" /></a>